214 related articles for article (PubMed ID: 20440754)
1. Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir.
Diaconu I; Cerullo V; Escutenaire S; Kanerva A; Bauerschmitz GJ; Hernandez-Alcoceba R; Pesonen S; Hemminki A
J Gene Med; 2010 May; 12(5):435-45. PubMed ID: 20440754
[TBL] [Abstract][Full Text] [Related]
2. Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.
Thomas MA; Spencer JF; La Regina MC; Dhar D; Tollefson AE; Toth K; Wold WS
Cancer Res; 2006 Feb; 66(3):1270-6. PubMed ID: 16452178
[TBL] [Abstract][Full Text] [Related]
3. Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity.
Kanerva A; Raki M; Ranki T; Särkioja M; Koponen J; Desmond RA; Helin A; Stenman UH; Isoniemi H; Höckerstedt K; Ristimäki A; Hemminki A
J Gene Med; 2007 Jan; 9(1):3-9. PubMed ID: 17149790
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.
Bortolanza S; Bunuales M; Alzuguren P; Lamas O; Aldabe R; Prieto J; Hernandez-Alcoceba R
Cancer Gene Ther; 2009 Sep; 16(9):703-12. PubMed ID: 19229289
[TBL] [Abstract][Full Text] [Related]
5. HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.
Toth K; Spencer JF; Ying B; Tollefson AE; Wold WSM
Viruses; 2017 Jun; 9(6):. PubMed ID: 28608847
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.
Ying B; Tollefson AE; Spencer JF; Balakrishnan L; Dewhurst S; Capella C; Buller RM; Toth K; Wold WS
Antimicrob Agents Chemother; 2014 Dec; 58(12):7171-81. PubMed ID: 25224011
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds.
Toth K; Tollefson AE; Spencer JF; Ying B; Wold WSM
Antiviral Res; 2017 Oct; 146():121-129. PubMed ID: 28827083
[TBL] [Abstract][Full Text] [Related]
8. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.
Jogler C; Hoffmann D; Theegarten D; Grunwald T; Uberla K; Wildner O
J Virol; 2006 Apr; 80(7):3549-58. PubMed ID: 16537623
[TBL] [Abstract][Full Text] [Related]
9. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
Kirby TO; Rivera A; Rein D; Wang M; Ulasov I; Breidenbach M; Kataram M; Contreras JL; Krumdieck C; Yamamoto M; Rots MG; Haisma HJ; Alvarez RD; Mahasreshti PJ; Curiel DT
Clin Cancer Res; 2004 Dec; 10(24):8697-703. PubMed ID: 15623655
[TBL] [Abstract][Full Text] [Related]
10. Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters.
Bortolanza S; Alzuguren P; Buñuales M; Qian C; Prieto J; Hernandez-Alcoceba R
Hum Gene Ther; 2007 Aug; 18(8):681-90. PubMed ID: 17658991
[TBL] [Abstract][Full Text] [Related]
11. Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds.
Wold WS; Toth K
Adv Cancer Res; 2012; 115():69-92. PubMed ID: 23021242
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.
Morfin F; Dupuis-Girod S; Mundweiler S; Falcon D; Carrington D; Sedlacek P; Bierings M; Cetkovsky P; Kroes AC; van Tol MJ; Thouvenot D
Antivir Ther; 2005; 10(2):225-9. PubMed ID: 15865216
[TBL] [Abstract][Full Text] [Related]
13. Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5.
Tollefson AE; Ying B; Spencer JF; Sagartz JE; Wold WSM; Toth K
J Virol; 2017 May; 91(10):. PubMed ID: 28250128
[TBL] [Abstract][Full Text] [Related]
14. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
[TBL] [Abstract][Full Text] [Related]
15. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
16. Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters.
Toth K; Ying B; Tollefson AE; Spencer JF; Balakrishnan L; Sagartz JE; Buller RM; Wold WS
Viruses; 2015 Mar; 7(3):1409-28. PubMed ID: 25807051
[TBL] [Abstract][Full Text] [Related]
17. An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.
Phillips LM; Li S; Gumin J; Daou M; Ledbetter D; Yang J; Singh S; Parker Kerrigan BC; Hossain A; Yuan Y; Gomez-Manzano C; Fueyo J; Lang FF
Neuro Oncol; 2021 Nov; 23(11):1911-1921. PubMed ID: 34059921
[TBL] [Abstract][Full Text] [Related]
18. Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
Tollefson AE; Spencer JF; Ying B; Buller RM; Wold WS; Toth K
Antiviral Res; 2014 Dec; 112():38-46. PubMed ID: 25453340
[TBL] [Abstract][Full Text] [Related]
19. Syrian hamster tumor model to study oncolytic Ad5-based vectors.
Dhar D; Toth K; Wold WS
Methods Mol Biol; 2012; 797():53-63. PubMed ID: 21948468
[TBL] [Abstract][Full Text] [Related]
20. STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control.
Toth K; Lee SR; Ying B; Spencer JF; Tollefson AE; Sagartz JE; Kong IK; Wang Z; Wold WS
PLoS Pathog; 2015 Aug; 11(8):e1005084. PubMed ID: 26291525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
